These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26476207)

  • 1. ABO incompatible renal transplants and decreased likelihood for developing immune responses to HLA and kidney self-antigens.
    Subramanian V; Gunasekaran M; Gaut JP; Phelan D; Vachharajani N; Santos RD; Wellen J; Shenoy S; Mohanakumar T
    Hum Immunol; 2016 Jan; 77(1):76-83. PubMed ID: 26476207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy.
    Angaswamy N; Klein C; Tiriveedhi V; Gaut J; Anwar S; Rossi A; Phelan D; Wellen JR; Shenoy S; Chapman WC; Mohanakumar T
    Am J Transplant; 2014 Mar; 14(3):685-93. PubMed ID: 24410875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
    Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
    Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
    Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection.
    Gunasekaran M; Vachharajani N; Gaut JP; Maw TT; Delos Santos R; Shenoy S; Chapman WC; Wellen J; Mohanakumar T
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28639386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
    Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
    Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
    Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
    Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation.
    Jänigen BM; Salabè C; Glatz T; Thomusch O; Lässle C; Fichtner-Feigl S; Zschiedrich S; Pisarski P
    Langenbecks Arch Surg; 2019 Dec; 404(8):999-1007. PubMed ID: 31456076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant donor specific antibodies in ABO incompatible kidney transplantation - data from the Swiss transplant cohort study.
    Deng Y; Frischnknecht L; Wehmeier C; de Rougemont O; Villard J; Ferrari-Lacraz S; Golshayan D; Gannagé M; Binet I; Wirthmueller U; Sidler D; Schachtner T; Schaub S; Nilsson J
    Front Immunol; 2024; 15():1355128. PubMed ID: 38361942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.
    Dörje C; Mjøen G; Strøm EH; Holdaas H; Jenssen T; Øyen O; Akkök ÇA; Cvancarova M; Midtvedt K; Reisaeter AV
    Clin Transplant; 2015 Mar; 29(3):268-76. PubMed ID: 25644963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J; Lozano M; Blasco M; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyporesponsiveness against donor's ABO antigens of renal grafts after ABO-incompatible kidney transplantation.
    Tasaki M; Tateno H; Sato T; Narimatsu H; Saito K; Nakagawa Y; Aoki T; Kamimura M; Ushiki T; Takahashi K; Tomita Y
    Clin Exp Nephrol; 2023 Jan; 27(1):89-95. PubMed ID: 36209259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study.
    Kwon H; Kim JY; Kim DH; Ko Y; Choi JY; Shin S; Jung JH; Kim YH; Han DJ;
    Sci Rep; 2019 Dec; 9(1):18229. PubMed ID: 31796812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.
    Wang XD; Liu JP; Fan Y; Song TR; Shi YY; Li YM; Lv YH; Li XH; Huang ZL; Lin T
    Ann Transplant; 2020 Feb; 25():e920224. PubMed ID: 32029699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction.
    Lehnhardt AM; Strecker M; Eiermann T; Marget M; Thaiss F; Nashan B; Koch M
    Clin Transplant; 2015 Apr; 29(4):359-64. PubMed ID: 25627801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB; Orandi BJ; Waldram MM; Luo X; Nguyen AQ; Montgomery RA; Lentine KL; Segev DL
    Am J Kidney Dis; 2020 Nov; 76(5):616-623. PubMed ID: 32668318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis.
    Scurt FG; Ewert L; Mertens PR; Haller H; Schmidt BMW; Chatzikyrkou C
    Lancet; 2019 May; 393(10185):2059-2072. PubMed ID: 31006573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.